Home - Products - Others - Other Targets - Enmein, 13-deoxy-19-hydroxy-, (19R)-

Enmein, 13-deoxy-19-hydroxy-, (19R)-

CAS No. 16763-48-7

Enmein, 13-deoxy-19-hydroxy-, (19R)-( —— )

Catalog No. M29499 CAS No. 16763-48-7

Enmein, 13-deoxy-19-hydroxy-, (19R)- is an Enmein-?type diterpene derivative and can be used in the preparation of antitumor drugs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 264 Get Quote
5MG 403 Get Quote
10MG 592 Get Quote
25MG 888 Get Quote
50MG 1242 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Enmein, 13-deoxy-19-hydroxy-, (19R)-
  • Note
    Research use only, not for human use.
  • Brief Description
    Enmein, 13-deoxy-19-hydroxy-, (19R)- is an Enmein-?type diterpene derivative and can be used in the preparation of antitumor drugs.
  • Description
    Enmein, 13-deoxy-19-hydroxy-, (19R)- is an Enmein-?type diterpene derivative and can be used in the preparation of antitumor drugs.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16763-48-7
  • Formula Weight
    362.42
  • Molecular Formula
    C20H26O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O[C@H]1[C@]2([C@@]3([C@]4([C@]5([C@H](O)[C@@H](CC4)C(=C)C5=O)C(=O)O[C@]3(CCC2(C)C)[H])[H])CO1)[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sibrotuzumab

    Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targeting Fibroblast Activating Protein (FAP) and is used in the study of colorectal cancer and non-small cell lung cancer.

  • Cys-CD36 (139-155)

    CD36 Peptide P (139-155), Cys conjugated is a Cys labelled CD36 Peptide, and can inhibit the immunoadsorption of CD36 by OKM5.

  • Kras4B G12D-IN-1

    Kras4B G12D-IN-1 is an anticancer agent that functions as an inhibitor of the Kras4B G12D protein. It effectively reduces the expression of Kras protein in mouse embryonic fibroblasts (MEFs) harboring the Kras4B G12D mutation.